Status: Recruiting
Study to Assess Safety and Tolerability of Multiple Doses of EO2002
The goal of this clinical study is to assess the safety of multiple intracameral injections of EO2002 with and without topical Ripasudil.
Participants needed: 12
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Asociación para Evitar la Ceguera en MéxicoUpdated: Dec 8, 2025Locations: 1
Eligibility criteria
Age ≥ 18 years. [+2]
Other corneal disease [+10]